The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for updated labeling of a resorbable implant for anterior cruciate ligament (ACL) repair, indicating a reduced risk of osteoarthritis.
Updated Labeling for ACL Implant
1 min read Premium comments

PremiumMiach Orthopaedicsknee osteoarthritisBEARGregory DiFelice
React:
